Thania Luiza de Andrade Sieiro1, Rafaela Baroni Aurílio2, Elizabeth Cristina C Soares3, Silvia S Chiang4, Clemax Couto Sant Anna5,6. 1. Centro de Saúde Vasco Barcelos, Secretaria Municipal de Saúde de Nova Iguaçu, Nova Iguaçu, RJ, Brasil. 2. Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. 3. Centro Administrativo São Sebastião, Secretaria Municipal de Saúde do Rio de Janeiro, Rio de Janeiro, RJ, Brasil. 4. Department of Pediatrics, Alpert Medical School of Brown University, Center for International Health Research, Rhode Island Hospital, Providence, USA. 5. Departamento de Pediatria, Faculdade de Medicina, Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil. 6. Rede TB de Pesquisa, Rede Nacional de Pesquisa em Tuberculose, Rio de Janeiro, RJ, Brasil.
Abstract
INTRODUCTION: The teste rápido molecular para tuberculose (TRM-TB) was introduced in 2014 in Brazil for tuberculosis screening. However, its role in adolescents in Brazil has not been studied. METHODS: A descriptive study of adolescents with suspected tuberculosis using National Laboratory software. RESULTS: Of 852 (15.4%) suspected cases, 131 were positive by TRM-TB and 2% were resistant to rifampicin. Among TRM-TB-positive cases, 105 (91.4%) were culture-positive. Sixty-four of 96 samples were sensitive to rifampicin by TRM-TB; 11 were resistant to other drugs by drug sensitivity test (DST). CONCLUSIONS: Among suspected cases, 16% were diagnosed by TRM-TB, of which 17% were drug-resistant by DST.
INTRODUCTION: The teste rápido molecular para tuberculose (TRM-TB) was introduced in 2014 in Brazil for tuberculosis screening. However, its role in adolescents in Brazil has not been studied. METHODS: A descriptive study of adolescents with suspected tuberculosis using National Laboratory software. RESULTS: Of 852 (15.4%) suspected cases, 131 were positive by TRM-TB and 2% were resistant to rifampicin. Among TRM-TB-positive cases, 105 (91.4%) were culture-positive. Sixty-four of 96 samples were sensitive to rifampicin by TRM-TB; 11 were resistant to other drugs by drug sensitivity test (DST). CONCLUSIONS: Among suspected cases, 16% were diagnosed by TRM-TB, of which 17% were drug-resistant by DST.
Authors: Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi Journal: Cochrane Database Syst Rev Date: 2022-09-06
Authors: Cinara Silva Feliciano; Lucas José Bazzo Menon; Livia Maria Pala Anselmo; Anzaan Dippenaar; Robin Mark Warren; Wilson Araújo Silva; Valdes Roberto Bollela Journal: ERJ Open Res Date: 2019-08-05
Authors: Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas Journal: Cochrane Database Syst Rev Date: 2020-08-27